Skip to content
problem genome

One of 592 unsolved problems in the Problem Genome, a collection written up for student design and engineering teams.

health

the exercise rarely handed out

Home balance exercises help chronic dizziness and have been packaged as booklets and free websites, yet primary care still rarely prescribes them, many trial patients did not report finishing them, and GPs keep prescribing anti-vertigo drugs with weak evidence

Source: Ngo et al., “Factors influencing appropriate vestibular care: An interview…” Open ↗source: primaryLast updated: 2026-11-12

Problem statement

When the inner-ear balance organs are damaged (by vestibular neuritis, for example), the brain can learn to compensate, and vestibular rehabilitation — simple daily head-movement and balance exercises — helps it do so. Trials in UK and Dutch general practice showed that the exercises can be delivered without a therapist, first as a self-management booklet and then as a free website. Yet the I-RECOVER team writes that vestibular rehabilitation "is underused in general practice, mostly due to a lack of knowledge," while "off-label anti-vertigo drugs are prescribed regularly, despite low quality of evidence," and the authors of a 2026 Swedish trial put uptake at under 5% of eligible primary-care patients, citing earlier UK studies; the Dutch team cites GP surveys in which only 6–7% of GPs used it. In routine records from 269 Dutch practices (2018–2021), 9% of an average cohort of 66,718 patients with vestibular symptoms received an anti-vertigo drug, 32% of them long term, though prescribing fell 21% over the three years. When patients do get the exercises, many do not finish them: in the UK booklet trial, 34% of those given the booklet alone and 44% of those also offered telephone support reported adhering to the full programme. Dutch GPs and patients interviewed for a 2025 study described why: GPs unsure of the diagnosis and the treatment, patients "desperate" to try anything and GPs accommodating them with drugs, and insurance not covering physiotherapy. The unsolved problem is getting a proven, cheap exercise programme into the consultation and keeping patients doing it at home — including the patients who cannot or will not use a website.

Why this matters

The I-RECOVER protocol says vestibular symptoms affect about 25% of the general population at some point and that 30–40% of patients with vestibular neuritis are still dizzy after six months; the Swedish authors cite dizziness as about 3% of emergency-department visits and report that, in Sweden, vestibular disorders have been identified as the leading cause of audiovestibular-related sick leave. Chronic dizziness can cause anxiety and limit activity, and the UK trial describes these patients as "currently very poorly served." The treatment is cheap and already proven in primary-care trials, so the gap is in delivery rather than in the science.

What’s been tried and why it hasn’t worked

(1) Booklet-based self-management (UK, 2008–2011). In 35 practices across southern England, 337 adults with chronic dizziness were randomised; at one year both booklet groups improved significantly relative to routine care, and the authors concluded the booklet is "a simple and cost effective means of improving patient reported outcomes." But only 34–44% reported adhering to the full programme, and more than a quarter of those offered telephone support did not take it up. (2) Internet-based rehabilitation. Self-help exercise programmes were then put online (Balance Retraining in the UK and a Dutch version, Vertigo Training), which a Dutch trial found effective up to 36 months, and which was "developed to increase uptake." In a 2026 Swedish trial of 184 patients with acute vertigo recruited at nine hospitals, though, the online tool was "not superior to written instructions," both groups improved, and the authors conclude that "ensuring access to vestibular rehabilitation exercises may be more important than the specific mode of delivery"; daily compliance was high in both arms (64–69% in weeks 5–6). The same trial excluded 15 patients for lack of access to or proficiency with digital technology and 10 for poor understanding of Swedish, and its authors warn that adherence in a trial "may exceed what is typically achieved under routine clinical conditions." (3) Nationwide implementation. The Netherlands began a national rollout of Vertigo Training with a multicomponent strategy (I-RECOVER, protocol 2023: guideline adaptations, marketing, pharmacotherapeutic audit and feedback, education, clinical decision support and local champions), measuring referrals and anti-vertigo prescriptions before and after; no results were found in this search. The interviews published in 2025, done as part of that rollout's pre-implementation phase, show the barriers are not only logistic: one widowed patient said, "I really dreaded the exercises, even though I knew they worked… since he passed away, I definitely have not been doing them." (4) Apps with feedback. A 2026 pilot crossover trial of a smartphone app (Vestibulon) in 20 adults found that both groups (app first and conventional first) improved over the six weeks, a pilot result that does not yet show better adherence. A commercial sensor system also exists: a wearable head sensor with app and clinician software (Vertigenius) was tested in 16 people with multiple sclerosis in a specialist-physiotherapy setting, with digitally measured adherence of 60%.

What would unlock progress

The pieces exist; what is missing is the hand-off and the follow-through. The interview study points to GP-facing support that turns diagnostic insecurity into a confident prescription at the moment of consultation, offered instead of the anti-vertigo drug the patient is asking for. I-RECOVER already bundles education, clinical decision support and audit and feedback for Dutch GPs, so the open questions are whether that bundle changes prescribing (results not yet published) and what a version would need outside a system with a national GP guideline and a free Dutch-language website. On the patient side, what is missing is a programme that gives the feedback, routine and social support the booklet alone lacked. The Swedish exclusions show that any solution has to work without a smartphone or in a second language. Whether the Dutch national rollout changes GP behaviour is the obvious next result to watch; a team should check for I-RECOVER results before starting.

How we’d know it’s being solved

(a) Share of new primary-care dizziness consultations that end with vestibular rehabilitation prescribed, and share ending with an anti-vertigo drug (two of the outcomes I-RECOVER tracks in routine data); (b) share of patients still doing the exercises at 9–12 weeks, measured objectively where possible rather than by recall; (c) Vertigo Symptom Scale–Short Form change (the Swedish trial prespecified a ≥3-point difference as clinically significant, citing Geraghty 2017 and Yardley 2004). Beware the proxy: website registrations measure access, not exercise.

Where to start

Facility-free door: design and usability-test a non-digital or low-literacy version of the programme (a printed progression card, a pictogram sequence, an audio-guided phone line) with older adults, people without digital access or skills and people with a poor grasp of the local language (the last two being groups the Swedish trial had to exclude); measure whether users perform the head movements correctly from the materials alone. Design door: prototype a "prescription pad" for GPs — a one-page decision aid plus a hand-over pack — that answers the insecurities named in the 2025 interviews, starting from what I-RECOVER's decision support and education already cover, and test it with GP trainees on case vignettes. Sensing door: a commercial head-sensor system exists for physiotherapist-supervised care (Vertigenius); prototype a cheaper, no-extra-hardware way to confirm exercises are done on the self-management route (a phone's own motion sensors counting head-turn repetitions), bench-tested against video. Partner door (design the trial, don't run it): with a primary-care network, design a pragmatic cluster trial comparing usual care with the prescription pad plus programme, with prescribing data as the primary outcome. Relevant skills: service and communication design, accessibility, interaction design, embedded sensing, primary-care input.

Genes

Related problems

Stuck the same way, in other fields.

field: the built worldhydrogen at $5–7 a kilo, against a $1 targetThree hydrogen truck companies collapsed within four months, with clean hydrogen at $5–7 a kilogram against a $1 target and limited refuelingbuilt without the people who'd live with itsource: secondaryfield: food & the living worldthe kilns changed, the workers didn'tIndia's 50,000 brick kilns must convert to cleaner technology by mandate — but 43% of converted kilns surveyed in bihar operate inefficiently because the workforce transition was never designedbuilt without the people who'd live with itsource: secondaryfield: digital & spaceentitled, but unenrolledAn estimated quarter of India's legislated welfare benefits never reach the people entitled to them because they can't navigate the paperworkbuilt without the people who'd live with itsource: primaryfield: making & materialsno stamp of approval for a second lifeNo one can certify whether a reused part is good enough to use againbuilt without the people who'd live with itsource: primary

Sources

  • Ngo HTN, Maarsingh OR, Slottje P, Blanker MH, Bont J, van Vugt VA. "Factors influencing appropriate vestibular care: An interview study with general practitioners and patients." The European journal of general practice 2025, doi:10.1080/13814788.2025.2600144, accessed 2026-10-22. Link ↗
  • Surano S, Lindell E, Mathé J, Davidsson H, Tomanovic T, Bjurman M, Faergemann E, Ledin T, Rostmark A, Grip H, Öhberg F, Granåsen G, Salzer J. "Internet-based vestibular rehabilitation versus written instructions after acute vertigo: A randomised controlled trial." PloS one 2026, doi:10.1371/journal.pone.0351092, accessed 2026-10-22. Link ↗
  • Ngo HTN, Maarsingh OR, van de Berg R, et al. "Study protocol for a nationwide implementation of internet-based vestibular rehabilitation for patients with chronic vestibular symptoms (I-RECOVER)." Implementation science communications 2023, doi:10.1186/s43058-023-00524-1, accessed 2026-10-22. Link ↗
  • Yardley L, Barker F, Muller I, Turner D, Kirby S, Mullee M, Morris A, Little P. "Clinical and cost effectiveness of booklet based vestibular rehabilitation for chronic dizziness in primary care: single blind, parallel group, pragmatic, randomised controlled trial." BMJ (Clinical research ed.) 2012, doi:10.1136/bmj.e2237, accessed 2026-10-22. Link ↗
  • Ngo HT, Maarsingh OR, Slottje P, Blanker MH, Groenhof F, Bont J, van Vugt VA. "Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study." BJGP open 2025, doi:10.3399/bjgpo.2025.0052, accessed 2026-10-22. Link ↗
  • Meldrum D, Kearney H, Hutchinson S, McCarthy S, Quinn G. "Wearable sensor and smartphone assisted vestibular physical therapy for multiple sclerosis: usability and outcomes." Frontiers in rehabilitation sciences 2024, doi:10.3389/fresc.2024.1406926, accessed 2026-10-22. Link ↗

Also cited in the brief

  • Geraghty et al. 2017 (publisher PDF) Link ↗
  • Kaplan et al. 2026 (Vestibulon pilot, n = 20) Link ↗
Revision notes

This brief gets checked against its sources and contains the following revisions. Future revisions get added here.

Worth knowing

  • The figure that under 5% of patients are offered this rehabilitation is the Swedish authors' own; the paper they cite for it does not give it. An earlier UK trial found 3% of its participants had been offered it before.

Full check

Sources read

  • Ngo et al., GP and patient interviews (European Journal of General Practice, 2025): full text
  • Surano et al., Swedish internet-based rehabilitation trial (PLoS One, 2026): full text
  • Ngo et al., I-RECOVER study protocol (2023): full text
  • Yardley et al., booklet-based rehabilitation trial (BMJ, 2012): full text
  • Ngo et al., anti-vertigo drug prescribing in Dutch primary care (BJGP Open, 2025): full text
  • Meldrum et al., sensor-based exercise system in multiple sclerosis (Frontiers in Rehabilitation Sciences, 2024): full text
  • Kaplan et al., app-based rehabilitation pilot (JMIR Rehabilitation and Assistive Technologies, 2026): full text
  • Geraghty et al., internet-based rehabilitation trial (Annals of Family Medicine, 2017): full text
  • Yardley et al., earlier UK rehabilitation trial (Annals of Internal Medicine, 2004): abstract only (the full text could not be obtained)

What changed

  • Stated more strongly than the source: the two kinds of prescribing are now two of the outcomes the Dutch rollout tracks, not its only two; commercial sensor systems: the sources name one, and the page now says one exists.
  • Numbers: the 9% given anti-vertigo drugs is now a share of an average cohort of 66,718 patients, as the study counted it.

Left open

  • the under-5% uptake figure and the 3-point improvement threshold, both given by the Swedish authors (their underlying source could not be read past its abstract)
  • the two GP surveys behind the 6–7% figure (not read)

Separate check of specific claims: The notes on which sources were read in full were brought up to date, adding that one cited paper does not give the under-5% figure.

Separate check of specific claims: A sick-leave statement now follows the Swedish authors' wording, and a mention of a review that could not be found was removed.

Earlier full check: Three claims were brought in line with the sources: what chronic dizziness can cause, what an app pilot found, and which groups a Swedish trial left out.

Separate check of specific claims: The titles were toned down to say this rehabilitation is rarely prescribed and that anti-vertigo drugs with weak evidence are still given (display title now The Exercise Rarely Handed Out), adherence is now described as reported by trial patients, and a Dutch prescribing study and a sensor-based exercise system were added.